From October 1 to 2, 2024, the Clusters of Excellence "Balance of the Microverse" (Jena), "CMFI" (Tübingen), and "RESIST" (Hannover) hosted the symposium "Microbes – Connecting Environment and Health" at the Berlin Futurium. The event brought together researchers and professionals to discuss antimicrobial resistance, microbial resilience, infection susceptibility, and the role of the microbiome in health.
In our film portrait, we introduce you to the scientific work of the RESIST Cluster of Excellence - and what drives us to conduct research for the weakest. Learn more about our research
Our RESIST scientists report here about the infection research for which they "burn"! They have placed themselves in front of the camera so that you can find out at the click of a mouse what the research in RESIST is all about and with what aim and with what passion it is carried out. Take a look for yoursel - Click here and you will get to the youtube-video! More information about our research
What is the RESIST Cluster of Excellence researching? Our speaker Prof. Dr. Thomas Schulz provides answers in the film. Learn more about our research
Every third thursday of the month the Cluster of Excellence RESIST ‘Resolving Infection Susceptibility‘ offers a seminar that takes place in the Lecture Hall Q, Building I06, MHH, at 5 pm. On November 21 Professor Dr. Immo Prinz and Professor Dr. Dorothee Viemann presented their current projects followed by ten minutes of discussion with the audience. Do you have any questions or suggestions regarding the RESIST seminar series? If so, please contact us! As a member of RESIST or of the SFB 900, as a colleague or student, visit these exciting seminars of the Cluster of Excellence RESIST. [...]
Wenn das Immunsystem es nicht alleine schafft: Mit einer Podiumsdiskussion veranschaulichten RESIST-Forscherinnen und Forscher am 1. Oktober von 19-21 Uhr im Tagungszentrum Schloss Herrenhausen, woran sie arbeiten – und für wen. Dabei stellten auch Patientinnen und Patienten sowie Vertreterinnen und Vertreter von Patientenorganisationen sowie ihre Ärztinnen und Ärzte ihre Sicht der Dinge dar. Der Abend stieß auf reges Interesse: Rund 230 Gäste füllten den Saal. Es war ein spannender Abend rund um das Thema „Infektionsanfälligkeit“ anhand der Gebiete Frühgeburt, angeborene Immunschwächen, Mukoviszidose und Hepatitis. Er machte deutlich, wie wichtig die RESIST-Forschung für die Patientinnen und Patienten ist. [...]
In order to better understand the factors underlying individual susceptibility to infectious diseases, numerous experts met from 30 September to 1 October 2019 for the first "Hannover Symposium on Infection Susceptibility". The photo shows the participants in front of and on the stairs of "Schloss Herrenhausen". You can find the programme of the symposium here. More information about our research
If the immune system is too weak: RESIST researchers are going to present what they are working on – and for whom – with a panel discussion at Herrenhausen Palace conference centre on 1st of October. Patients and representatives of patient organisations as well as their physicians are also going to introduce their view on things. Everyone interested is invited and of course questions are welcome. An exciting evening concerning the topic “susceptibility to infections” based on the fields premature birth, congenital immunodeficiencies, cystic fibrosis and hepatitis lies ahead. Come by, entry is free. The event will be hosted [...]
"I am very pleased that our Cluster of Excellence RESIST has now its own homepage and I cordially invite you to take a look at it," says RESIST speaker Professor Dr. Thomas Schulz. Click on "About us" and get an impression of our researchers and the speaker trio. A click on "Research" tells you how diverse and networked the projects are. This homepage will be expanded continuously. More information about our research
Some people become only mildly ill when they ’catch’ viral or bacterial infections, whereas others are affected much more severely. But what are the reasons for these differences? And how can the course of a disease be predicted and personalized treatments developed? These questions are being addressed by the RESIST Cluster of Excellence team. This will enable them to help people with a weakened immune system, including newborn babies, the elderly, people with congenital immunodeficiency, those whose immune system is suppressed for therapeutic reasons, and implant users. Learn more about our research
